Metformin was found in another study to induce cell cycle arrest in rheumatoid arthritis fibroblast-like synoviocytes, and that this effect could be due to inhibiting IGF-IR/PI3K/AKT/m-TOR pathway (Chen et al. 2019). The gene discussed is AKT1; the disease is rheumatoid arthritis.